Search

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.

… Thursday, July 3, 2014 Summary Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story. “Celebrating survivorship is an important reminder of why MSK exists.” —Memorial Sloan

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

… Thursday, June 7, 2018 Summary A collaborative study between scientists at Memorial Sloan Kettering and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported in the Proceedings of the National Academy of Sciences, pave

Radiologist and molecular imaging researcher Moritz Kircher was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization of glioblastomas.

… Wednesday, November 30, 2011 Radiologist and molecular imaging researcher Moritz Kircher  was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization

A new drug is showing very encouraging results against pancreatic cancer, thanks to clinical trials of daraxonrasib at MSK and other hospitals.

… Thursday, May 7, 2026 A drug that may offer new hope for people facing pancreatic cancer has been authorized by the U.S. Food & Drug Administration (FDA) for expanded access, meaning more patients can take the drug while it is being studied.  Pancreatic cancer is one of the most aggressive types of cancer

Read how prostate cancer screening saved a man's life and inspired his activism for cancer awareness in the Black community.

… Friday, May 8, 2026   It started with a simple blood test. Eddie Baynes, a finance executive at Verizon and a proud Morehouse College graduate, joined a prostate cancer awareness drive with his fraternity brothers of Alpha Phi Alpha Fraternity, Inc. One of them, Derrick Butts, had survived the disease

… Tuesday, May 5, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Christopher D. Lima Elected 2025 AAAS Fellow   Christopher D. Lima Christopher D. Lima, PhD, Chair of the Structural Biology Program at the Sloan Kettering Institute and a Howard Hughes

Learn how MSK is making clinical trials more accessible through innovative new approaches that bring care to people's homes and make participating possible even for people who live far from MSK.

… Monday, May 11, 2026 At the heart of clinical trials lies hope. They are research studies seeking better ways to treat or prevent cancer. They offer a chance to live better and longer. They drive advances that will help future generations. Clinical trials are the bridge between promising scientific discoveries

Learn why immuno-oncology — which seeks to rally and strengthen the immune system’s ability to fight cancer — is the world’s next frontier in cancer research, and how MSK is overcoming some of the field's biggest challenges.

… Monday, May 11, 2026 At any given moment, the human immune system is running quiet surveillance: detecting what doesn’t belong and calibrating a response strong enough to clear infection but restrained enough to avoid harming healthy cells and tissues. That discrimination is the immune system’s defining

Learn more about what the Gerstner Sloan Kettering Graduate School of Biomedical Sciences offers aspiring scientists from three distinguished alumni of the program.

… Monday, May 11, 2026 Curiosity, focus, and commitment are essential qualities for an aspiring scientist. But speak to any accomplished researcher and they will tell you strong mentorship matters most of all.  That’s why, nearly 20 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical

Every year, thousands of people travel from across the country and around the world in search of hope at MSK. Learn how MSK supports patients far from home.

… Monday, May 11, 2026 Memorial Sloan Kettering Cancer Center (MSK) has always been a neighborhood hospital, focused on caring for New York City residents since welcoming its first patients in Manhattan, in 1887. Over the decades, MSK’s community has expanded to include the surrounding region, with locations